![From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d40697d-4d20-47cd-b489-b6be7c5fc305/gr1_lrg.jpg)
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal
![Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1a05d590-96b1-4169-b837-6095d4225c8b/gr1.gif)
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Davide Capodanno on Twitter: "ENTRUST-AF PCI completes the series of trials of NOAC-DAT vs VKA-TAT. If you want to read more, here is our commentary for The Lancet. https://t.co/326DTeHpiM https://t.co/TXliAi2lAq" / Twitter
![Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f910ed62-9a6a-47a3-a724-dfecec92de4a/gr2_lrg.jpg)
Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology
![Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter](https://pbs.twimg.com/media/D5ORU8GU0AEQK_8.jpg)
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
![Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/de92b71a-c6ca-4a4d-a5be-6c20525f240c/gr1.jpg)
Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology
![Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - The American Journal of the Medical Sciences Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - The American Journal of the Medical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/afc1eb4c-9882-4acd-b318-20ab013ee0d1/gr1.jpg)
Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - The American Journal of the Medical Sciences
![A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease - Canadian Journal of Cardiology A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease - Canadian Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/810e6ccc-4519-496f-bb12-839e3c6cab38/gr1_lrg.jpg)
A Critical Comparison of Canadian and International Guidelines Recommendations for Antiplatelet Therapy in Coronary Artery Disease - Canadian Journal of Cardiology
![The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/2017-11/CE78021B-FDD9-438F-9EBF-296EF9F7AE8E.png)